222 related articles for article (PubMed ID: 35606862)
1. Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy.
Okamura K; Nagayama S; Tate T; Chan HT; Kiyotani K; Nakamura Y
J Transl Med; 2022 May; 20(1):241. PubMed ID: 35606862
[TBL] [Abstract][Full Text] [Related]
2. CD4
Piersiala K; Farrajota Neves da Silva P; Hjalmarsson E; Kolev A; Kågedal Å; Starkhammar M; Elliot A; Marklund L; Margolin G; Munck-Wikland E; Kumlien Georén S; Cardell LO
Cancer Sci; 2021 Mar; 112(3):1048-1059. PubMed ID: 33462898
[TBL] [Abstract][Full Text] [Related]
3. TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients.
Matsuda T; Miyauchi E; Hsu YW; Nagayama S; Kiyotani K; Zewde M; Park JH; Kato T; Harada M; Matsui S; Ueno M; Fukuda K; Suzuki N; Hazama S; Nagano H; Takeuchi H; Vigneswaran WT; Kitagawa Y; Nakamura Y
Oncoimmunology; 2019; 8(6):e1588085. PubMed ID: 31069156
[TBL] [Abstract][Full Text] [Related]
4. Neoantigen-specific stem cell memory-like CD4
Brightman SE; Becker A; Thota RR; Naradikian MS; Chihab L; Zavala KS; Ramamoorthy Premlal AL; Griswold RQ; Dolina JS; Cohen EEW; Miller AM; Peters B; Schoenberger SP
Nat Immunol; 2023 Aug; 24(8):1345-1357. PubMed ID: 37400675
[TBL] [Abstract][Full Text] [Related]
5. PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes.
Nagasaki J; Inozume T; Sax N; Ariyasu R; Ishikawa M; Yamashita K; Kawazu M; Ueno T; Irie T; Tanji E; Morinaga T; Honobe A; Ohnuma T; Yoshino M; Iwata T; Kawase K; Sasaki K; Hanazawa T; Kochin V; Kawamura T; Matsue H; Hino M; Mano H; Suzuki Y; Nishikawa H; Togashi Y
Cell Rep; 2022 Feb; 38(5):110331. PubMed ID: 35108529
[TBL] [Abstract][Full Text] [Related]
6. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
[TBL] [Abstract][Full Text] [Related]
7. CD8
Prokhnevska N; Cardenas MA; Valanparambil RM; Sobierajska E; Barwick BG; Jansen C; Reyes Moon A; Gregorova P; delBalzo L; Greenwald R; Bilen MA; Alemozaffar M; Joshi S; Cimmino C; Larsen C; Master V; Sanda M; Kissick H
Immunity; 2023 Jan; 56(1):107-124.e5. PubMed ID: 36580918
[TBL] [Abstract][Full Text] [Related]
8. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
[TBL] [Abstract][Full Text] [Related]
9. Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cells.
Meijer SL; Dols A; Urba WJ; Hu HM; Smith II JW; Vetto J; Wood W; Doran T; Chu Y; Sayaharuban P; Alvord WG; Fox BA
J Immunother; 2002; 25(4):359-72. PubMed ID: 12142559
[TBL] [Abstract][Full Text] [Related]
10. Relationship between T cell receptor clonotype and PD-1 expression of tumor-infiltrating lymphocytes in colorectal cancer.
Sukegawa K; Shitaoka K; Hamana H; Kobayashi E; Miyahara Y; Fujii K; Tsuda K; Saeki S; Nagata T; Ozawa T; Saito S; Fujii T; Muraguchi A; Shiku H; Kishi H
Eur J Immunol; 2020 Oct; 50(10):1580-1590. PubMed ID: 32441316
[TBL] [Abstract][Full Text] [Related]
11. Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma.
Miller CH; Graham L; Bear HD
BMC Immunol; 2010 Nov; 11():54. PubMed ID: 21050466
[TBL] [Abstract][Full Text] [Related]
12. Rectal cancer induces a regulatory lymphocytic phenotype in the tumor-draining lymph nodes to promote cancer cell installation.
Giatromanolaki A; Koukourakis IM; Chatzipantelis P; Kouroupi M; Balaska K; Koukourakis MI
Immunol Res; 2020 Dec; 68(6):363-372. PubMed ID: 33150567
[TBL] [Abstract][Full Text] [Related]
13. T Cells Derived From Human Melanoma Draining Lymph Nodes Mediate Melanoma-specific Antitumor Responses In Vitro and In Vivo in Human Melanoma Xenograft Model.
Zhang M; Graor H; Visioni A; Strohl M; Yan L; Caja K; Kim JA
J Immunother; 2015; 38(6):229-38. PubMed ID: 26049546
[TBL] [Abstract][Full Text] [Related]
14. The primordial differentiation of tumor-specific memory CD8
Huang Q; Wu X; Wang Z; Chen X; Wang L; Lu Y; Xiong D; Liu Q; Tian Y; Lin H; Guo J; Wen S; Dong W; Yang X; Yuan Y; Yue Z; Lei S; Wu Q; Ran L; Xie L; Wang Y; Gao L; Tian Q; Zhou X; Sun B; Xu L; Tang Z; Ye L
Cell; 2022 Oct; 185(22):4049-4066.e25. PubMed ID: 36208623
[TBL] [Abstract][Full Text] [Related]
15. Adoptive CD8
Jiang X; Xu J; Liu M; Xing H; Wang Z; Huang L; Mellor AL; Wang W; Wu S
Cancer Lett; 2019 Oct; 462():23-32. PubMed ID: 31356845
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced suppression of antitumor reactivity and depression of TCRzeta expression in tumor-draining lymph node lymphocytes: possible relationship to the Th2 pathway.
Fu EJ; Arca MJ; Hain JM; Krinock R; Rado J; Cameron MJ; Chang AE; Sondak VK
J Immunother; 1997 Mar; 20(2):111-22. PubMed ID: 9087383
[TBL] [Abstract][Full Text] [Related]
17. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
[No Abstract] [Full Text] [Related]
18. Generation of colon cancer-derived tumor-infiltrating T cells (TILs) for adoptive cell therapy.
Albrecht HC; Gustavus D; Schwanemann J; Dammermann W; Lippek F; Weylandt KH; Hoffmeister H; Gretschel S
Cytotherapy; 2023 May; 25(5):537-547. PubMed ID: 36775787
[TBL] [Abstract][Full Text] [Related]
19. Significance of TIM-3 expression by CD4
Shariati S; Ghods A; Zohouri M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Mol Immunol; 2020 Dec; 128():47-54. PubMed ID: 33068833
[TBL] [Abstract][Full Text] [Related]
20. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
